Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glutathione and Valproic Acid

supplement:

Glutathione

Research Papers that Mention the Interaction

During the treatment with VPA or CBZ, the erythrocyte GSHpX and GSH levels of epileptic children were significantly changed as compared to those of health control subjects.
Pharmacological research  •  2000  |  View Paper
VPA exposure altered the activities of glutathione metabolizing enzymes such as glutathione-S-transferase, glutathione peroxidase, and glutathione reductase.
Protoplasma  •  2014  |  View Paper
Further, we found that chronic treatment with lithium and valproate increased glutathione levels in primary cultured rat cerebral cortical cells and that the effects of lithium and valproate on glutathione levels were dose-dependent in human neuroblastoma SH-SY5Y cells.
These results suggest that glutathione plays an important role in the neuroprotective effects of lithium and valproate , and that glutathione may be a common target for mood stabilizing drugs.
Neuroscience  •  2007  |  View Paper
With respect to ROS and GSH levels, VPA increased ROS levels and induced GSH depletion.
Oncology reports  •  2013  |  View Paper
VPA , which is an anti-epileptic drug in widespread use in clinical medicine, has been shown to depress the activity of GSH reductase , an enzyme required for maintaining high cellular levels of reduced GSH.
The Journal of general virology  •  1996  |  View Paper
GSH assays showed that VPA treatment led to a decrease in the intracellular level of this thiol compound in U937 (U1 parent-cell line) and in Jurkat T-cells.
Chemico-biological interactions  •  1994  |  View Paper
VPA promoted angiogenesis by enhancing vascular endothelial growth factor (VEGF) mRNA transcription and upregulating VEGF and cadherin 5 expression, inhibited apoptosis via reduction of caspase 3 cleavage, and relieved oxidative stress by increasing superoxide dismutase (SOD) and glutathione (GSH) levels and reducing the malondialdehyde (MDA) level.
Drug design, development and therapy  •  2018  |  View Paper
GSH and SOD activity were significantly reduced by valproate and levetiracetam treatment.
The Indian journal of medical research  •  2016  |  View Paper
Additionally, VPA administration leaded to depletion of reduced glutathione and decrease in total antioxidant potential in testes and epididymides of Wistar rats.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie  •  2016  |  View Paper
VPA treatment decreased the ROS generation (P<0.01), decreased the MDA levels (P<0.01), increased the GSH levels (P<0.01) and increased the SOD activity (P<0.01).
Neuroscience  •  2016  |  View Paper
Show More